Nucs AI Resourses

Discover the latest news, research and publications driving advancements in prostate cancer treatment.

News
Publications
2
min read

Nucs AI Wins Cannes Neuron Award for Healthcare Innovation

Nucs AI, a leader in AI-driven radiology solutions, is proud to announce that it has been awarded the prestigious Cannes Neuron Award in the Healthcare category.
Read more

Other News

News
3
min read

Nucs AI closes $3.5 million in seed funding round

Medtech startup Nucs AI has raised $3.5 million Seed funding. Founded in 2023 in Berlin and headquartered in San Francisco, Nucs AI uses precision medicine to diagnose and treat prostate cancer.
Read more
4
min read

[68Ga]Ga-PSMA-11 PET Tumor Volume Predicts Overall Survival of Patients with Metastatic Prostate Cancer Undergoing Taxane-Based Chemotherapy

Quantitative parameters proven to prognosticate after taxane-based chemotherapy in mCRPC patients.
Read more

Other Publications

5
min read

Artificial intelligence to predict outcome after [177Lu]Lu-PSMA for metastatic castration-resistant prostate cancer: Preliminary results from a multicentric prospective study

Preliminary multicenter results show SelectPSMApredicts which mCRPC patients will respond to 177-Lu-PSMA therapy.
Read more
5
min read

Prognostic Value of Quantitative PSMA-PET Parameters during Chemotherapy in Prostate Cancer

A multi-center study exploring the prognostic value of PSMA-PET/CT quantitative parameters during chemotherapy in prostate cancer.
Read more
4
min read

Initial Experience with [177Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction

Andrei Gafita, Andrew Voter, Somya Shesadri, Avery Spitz, Catherine H. Marshall, Steven P. Rowe, Mark C. Markwoski, Martin G. Pomper, A. Cahid Civelek, Michael A. Carducci,
Read more